Therapeutic Drug Monitoring of Voriconazole in the Management of Invasive Fungal Infections: A Critical Review
出版年份 2015 全文链接
标题
Therapeutic Drug Monitoring of Voriconazole in the Management of Invasive Fungal Infections: A Critical Review
作者
关键词
Voriconazole, Therapeutic Drug Monitoring, Invasive Aspergillosis, Trough Concentration, Invasive Fungal Infection
出版物
CLINICAL PHARMACOKINETICS
Volume 54, Issue 12, Pages 1223-1235
出版商
Springer Nature
发表日期
2015-06-12
DOI
10.1007/s40262-015-0297-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- CYP2C19Polymorphisms and Therapeutic Drug Monitoring of Voriconazole: Are We Ready for Clinical Implementation of Pharmacogenomics?
- (2014) Aniwaa Owusu Obeng et al. PHARMACOTHERAPY
- Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events
- (2013) Helen Y Chu et al. BMC INFECTIOUS DISEASES
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
- (2013) S A Scott et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
- (2013) H. R. Ashbee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity
- (2012) Dimitra Mitsani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial
- (2012) Wan Beom Park et al. CLINICAL INFECTIOUS DISEASES
- Antifungal prophylaxis in haematology patients: the role of voriconazole
- (2012) Y. Hicheri et al. CLINICAL MICROBIOLOGY AND INFECTION
- Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience
- (2012) Zdenek Racil et al. MYCOSES
- Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Children and Healthy Adults
- (2011) Timothy A. Driscoll et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients
- (2011) Peter F. Troke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients
- (2011) Si-Hyun Kim et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Modulators of Very Low Voriconazole Concentrations in Routine Therapeutic Drug Monitoring
- (2011) Arwa Hassan et al. THERAPEUTIC DRUG MONITORING
- Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism
- (2010) Hui-Yan Shi et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype
- (2009) Ina Scholz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
- (2009) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Voriconazole concentrations and outcome of invasive fungal infections
- (2009) S. Miyakis et al. CLINICAL MICROBIOLOGY AND INFECTION
- Correlation between voriconazole trough plasma concentration and hepatotoxicity in patients with different CYP2C19 genotypes
- (2009) Kazuaki Matsumoto et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders
- (2009) Koki Ueda et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers
- (2008) Guo Wang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- CYP2C19Genotype Is a Major Factor Contributing to the Highly Variable Pharmacokinetics of Voriconazole
- (2008) Johanna Weiss et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started